NEW YORK, March 16 (GenomeWeb News) - Aiming to increase its presence in molecular diagnostics, Fisher Scientific will acquire privately held Athena Diagnostics and has paid $15 million in cash for a 9-percent stake in Nanogen, the company said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.